Research Article| Volume 34, ISSUE 4, P514-521, August 2021

Provider Attitudes and Practices Regarding Intrauterine System (IUS) Insertion in Adolescents With and Without Bleeding Disorders for Management of Heavy Menstrual Bleeding

Published:January 22, 2021DOI:


      Study Objective

      Heavy menstrual bleeding (HMB) may be the sentinel event for identifying a patient with a bleeding disorder (BD). The levonorgestrel intrauterine system (LNG IUS) has been proposed as a treatment for HMB in adolescents with and without BDs; however, no standard protocols for LNG IUS insertion in these populations exist. Providers were surveyed regarding the use of the LNG IUS in adolescents with HMB, with and without BD.

      Design, Setting, Participants, Interventions, and Main Outcome Measures

      An institutional review board−approved survey assessing provider attitudes, LNG IUS insertion practices, and patient outcomes in adolescents with HMB, with and without BD, was electronically distributed to 3523 providers in the fields of hematology, adolescent medicine, and obstetrics and gynecology. Descriptive analysis was performed.


      A total of 312 respondents across all 3 specialties completed the survey. Nearly 100% of respondents considered the LNG IUS safe and effective treatment for adolescents with HMB, both with and without BD. Additionally, 66% of providers chose LNG IUS as the ideal treatment for HMB in patients with BD. Differences were noted in clinical setting for LNG IUS insertion, peri-procedural medication use, and post-procedure follow-up among specialties. Providers across all specialties reported low complication rates related to IUS insertion and use in both patient groups.


      Providers considered the LNG IUS safe and effective treatment for HMB in adolescents with and without a diagnosed BD. Practice patterns regarding LNG IUS insertion in this population vary. Further research is necessary to explore IUS outcomes in adolescent patients with HMB, with and without BD, and to inform evidence-based protocols for LNG IUS insertion.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Haamid F.
        • Sass A.E.
        • Dietrich J.E.
        Heavy menstrual bleeding in adolescents.
        J Pediatr Adolesc Gynecol. 2017; 30: 335
        • Smith Y.R.
        • Quint E.H.
        • Hertzberg R.B.
        Menorrhagia in adolescents requiring hospitalization.
        J Pediatr Adolesc Gynecol. 1998; 11: 13
        • Seravalli V.
        • Linari S.
        • Peruzzi E.
        • et al.
        Prevalence of hemostatic disorders in adolescents with abnormal uterine bleeding.
        J Pediatr Adolesc Gynecol. 2013; 26: 285
        • Oral E.
        • Cağdaş A.
        • Gezer A.
        • et al.
        Hematological abnormalities in adolescent menorrhagia.
        Arch Gynecol Obstet. 2002; 266: 72
        • Philipp C.S.
        • Faiz A.
        • Dowling N.
        • et al.
        Age and the prevalence of bleeding disorders in women with menorrhagia.
        Obstet Gynecol. 2005; 105: 61
        • Jayasinghe Y.
        • Moore P.
        • Donath S.
        • et al.
        Bleeding disorders in teenagers presenting with menorrhagia.
        Aust N Z J Obstet Gynaecol. 2005; 45: 439
        • Mikhail S.
        • Varadarajan R.
        • Kouides P.
        The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre.
        Haemophilia. 2007; 13: 627
        • Hernandez A.
        • Dietrich J.E.
        Abnormal uterine bleeding in the adolescent.
        Obstet Gynecol. 2020; 135: 615
        • Davies J.
        • Kadir R.A.
        Heavy menstrual bleeding: an update on management.
        Thromb Res. 2017; 151: S70
      1. Committee on Adolescence: Contraception for adolescents.
        Pediatrics. 2014; 134: 1244
      2. ACOG Committee opinion no. 735: zdolescents and long-acting reversible contraception: implants and intrauterine Devices.
        Obstet Gynecol. 2018; 131: e130
      3. ACOG Committee opinion no. 785: screening and management of bleeding disorders in adolescents with heavy menstrual bleeding.
        Obstet Gynecol. 2019; 134: e71
        • Andersson J.K.
        • Rybo G.
        Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.
        Br J Obstet Gynaecol. 1990; 97: 690
        • Lethaby A.
        • Hussain M.
        • Rishworth J.R.
        • et al.
        Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
        Cochrane Database Syst Rev. 2015; 4CD002126
        • Kingman C.E.
        • Kadir R.A.
        • Lee C.A.
        • et al.
        The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.
        BJOG. 2004; 111: 1425
        • Chi C.
        • Huq F.Y.
        • Kadir R.A.
        Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.
        Contraception. 2011; 83: 242
        • Kouides P.
        • Phatak P.
        • Sham R.
        • et al.
        The efficacy and safety of the levonorgestrel intrauterine device (Mirena) for bleeding disorder-related menorrhagia in an American cohort.
        Hemophilia. 2006; 12: 146
        • Rimmer E.
        • Jamieson M.A.
        • James P.
        Malposition and expulsion of the levonorgestrel intrauterine system among women with inherited bleeding disorders.
        Haemophilia. 2013; 19: 933
        • Adeyemi-Fowode O.A.
        • Santos X.M.
        • Dietrich J.E.
        • et al.
        Levonorgestrel-releasing intrauterine device use in female adolescents with heavy menstrual bleeding and bleeding disorders: single institution review.
        J Pediatr Adolesc Gynecol. 2017; 30: 479
        • Alaqzam T.S.
        • Stanley A.C.
        • Simpson P.M.
        • et al.
        Treatment modalities in adolescents who present with heavy menstrual bleeding.
        J Pediatr Adolesc Gynecol. 2018; 31: 451
        • Dean G.
        • Schwarz E.B.
        • et al.
        Intrauterine Contraceptives (IUCs).
        in: Hatcher R.A. Trussell J. Nelson A.L. Contraceptive Technology. Ardent Media, Inc, New York, NY2011: 147-191